Lidocaine in the treatment of status epilepticus

Academic Emergency Medicine

Volumn 4, Issue 9, 1997, Pages 918-925

  Walker, L Anderson ^a   Slovis, Corey M ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Lidocaine; Literature review; Seizure; Status epilepticus

Indexed keywords

DIAZEPAM; FOSPHENYTOIN SODIUM; LIDOCAINE; LORAZEPAM; PENTOBARBITAL; PHENOBARBITAL; PHENYTOIN; THIOPENTAL;

ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EPILEPTIC STATE; HEART ARRHYTHMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030874888     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1553-2712.1997.tb03820.x     Document Type: Article

References (38)

1. Bernhard CG, Bohm E, Hojeberg S. A new treatment of status epilepticus - intravenous injection of local anesthetic (lidocaine). Arch Neurol Psychiatry. 1955; 74:208-14.
2. Pascual J, Sedano MJ, Polo JM, Berciano J. Intravenous lidocaine for status epilepticus. Epilepsia. 1988; 29:584-9.
3. Hellstrom-Westas L, Westgren U, Rosen I, Svenningsen NW. Lidocaine for treatment of severe seizures in newborn infants 1 - clinical effects and cerebral electrical activity monitoring. Acta Pediatr Scand. 1988, 77:79-84.
4. Hellstrom-Westas L, Svenningsen NW, Rosen I, Lagerstrom PO. Lidocaine for treatment of severe seizures in newborn infants II - blood concentrations of lidocaine and metabolites during intravenous infusion. Acta Pediatr. 1992; 81 35-9.
5. Rey E, Radvanyi-Bouvet MF, Bodiou C, et al Intravenous lidocaine in the treatment of convulsions in the neonatal period-monitoring plasma levels Ther Drug Monit. 1990; 12: 316-20.
6. DeGiorgio CM, Altman K, Hamilton-Byrd K, Rabinowicz AL. Lidocaine in refractory status epilepticus - confirmation of efficacy with continuous EEG monitoring. Epilepsia. 1992; 33:913-6.
7. Pascual J, Ciudad J, Berciano J. Role of lidocaine in managing status epileplicus. J Neurol Neurosurg Psychiatry. 1992; 55:49-51
8. Aggarwal P, Wali JP. Lidocaine in refractory status epilepticus - a forgotten drug in the emergency department Am J Emerg Med. 1993; 11:243-4.
9. Working Group on Status Epilepticus. Treatment of convulsive status epilepticus. JAMA. 1993; 270.854-9.
10. Watson C. Status epilepucus - clinical features, pathophysiology, and treatment. West J Med. 1991; 155:626-31.
11. Walsh GO, Delgado-Escueta AV. Status epilepticus. Neurol Clin. 1993, 11:835-56
12. Jagoda A. Riggio S Refractory status epilepticus in adults. Ann Emerg Med. 1993, 22: 1337-48.
13. Ramsey RE. Treatment of status epileplicus. Epilepsia. 1993; 34(suppl 1):S71-S81.
14. Treiman DA. Current treatment strategies in selected situations in epilepsy. Epilepsia. 1993; 34(suppl 5):S17-S23
15. Tunik MG, Young GM. Status epilepticus in children - the acute management. Pediatr Clin North Am. 1992; 39:1007-30.
16. Leppik IE. Status epilepticus - the next decade. Neurology. 1990; 40(suppl 2):4-9.
17. Shepard SM. Management of status epilepticus. Emerg Med Clin North Am. 1994, 12.941-61.
18. Sholtes FB, Renier WO, Meinardi H. Generalized convulsive status epilepticus - pathophysiology and treatment. Pharm World Sci. 1993; 15:17-28.
19. Shorvon S. Tonic clonic status epilepticus J Neurol Neurosurg Psychiatry. 1993; 56: 125-34.
20. Pellock JM. Status epilepticus in children - update and review. J Child Neurol. 1994; 9(suppl):2S27-2S35.
21. Roberts MR, Eng-Bourguin J. Status epilepticus in children. Emerg Med Clin North Am. 1995; 13:489-507.
22. Krishnamoorthy KS. Management of generalized tonic-clonic status epilepticus. Indian J Pediatr. 1994; 61:43-7.
23. Mitchell WG: Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome and treatment. Epilepsia. 1996; 37:S74-S80.
24. Hauser WA. Status epilepticus - epidemiologic considerations Neurology. 1990; 40(suppl 2):9-13.
25. De Lorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology. 1996; 46:1029-35.
26. Taverner D, Bain WA. Intravenous lidocaine as an anticonvulsant in status epilepticus and serial epilepsy. Lancet. 1958; 2:1145-7.
27. Westreich G, Kneller W. Intravenous lidocaine for status epilepticus. Minn Med. 1972; 55:807-8.
28. Lemmen LJ, Klassen M, Duiser B. Intravenous lidocaine in the treatment of convulsions. JAMA. 1978; 239:2025.
29. Morris HH. Lidocaine - a neglected anticonvulsant? South Med J. 1979; 72:1564-6.
30. Wallin A, Nergardh A, Hynning PA. Lidocaine treatment of neonatal convulsions, a therapeutic dilemma. Eur J Clin Pharmacol. 1989; 36:583-6.
31. Subcommittee on Advanced Cardiac Life Support: cardiovascular pharmacology I. In: Cummins RO (ed). Textbook of Advanced Cardiac Life Support, Dallas, TX: American Heart Association, 1994, pp 7-6-7-8.
32. Wikinski JA, Usubiaga JE, Morales RL, Torrieri A, Usubiaga LE. Mechanism of convulsions elicited by local anesthetic agents: I. Local anesthetic depression of electrically induced seizures in man. Anesth Analg. 1970; 49:504-10.
33. Ottoson JO. Effect of lidocaine on the seizure discharge in electroconvulsive therapy. Acta Psychiatr Scand. 1960; 35:7-29.
34. Hood DD, Mecca RS. Failure to initiate electroconvulsive seizures in a patient pretreated with lidocaine. Anesthesiology. 1983; 58:379-81.
35. Simon RP, Benowitz NL, Bronstein J, Jacob P III. Increased brain uptake of lidocaine during bicuculline-induced status epilepticus in rats. Neurology. 1982; 32:196-9.
36. Simon RP, Benowitz NL, Culala S. Motor paralysis increases brain uptake of lidocaine during status epilepticus. Neurology. 1984; 34: 384-7.
37. Seamans CM, Slovis CM. Seizures: current clinical guidelines for evaluation and emergency management, part II. Emerg Med Rep 1995; 16:31-8.
38. Delgado-Escueta AV, Wasterlain C, Triman DM, et al. Management of status epilepticus. N Engl J Med. 1982; 306:1337-40.